Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn’s Disease Patients Undergoing Multidetector CT-Enterography
Authors:
- Olga Maria NardoneONOlga Maria Nardone
- Andrea PonsiglioneAPAndrea Ponsiglione
- Roberto de SireRSRoberto de Sire
- Giulio CalabreseGCGiulio Calabrese
- Raffaele LiuzziRLRaffaele Liuzzi
- Anna TestaATAnna Testa
- Alessia Dalila GuarinoAGAlessia Dalila Guarino
- Oriana OlmoOOOriana Olmo
- Antonio RispoAntonio Rispo
- Luigi CameraLCLuigi Camera
- Fabiana CastiglioneFCFabiana Castiglione
Open Access
Abstract
(1) Background: Sarcopenia has a high incidence in Crohn’s disease (CD) with considerable heterogeneity among ethnicities and variable impact on clinical outcomes. Aim: to assess the impact of sarcopenia on clinical outcomes in a cohort of Caucasian patients with active CD undergoing CT-enterography (CTE) for clinical assessment. We further investigated the prevalence of sarcopenia and its predictors. (2) Methods: Caucasian CD patients with moderate–severe clinical activity, who underwent CTE in an emergency setting, were retrospectively recruited. The skeletal muscle index (SMI) at the third lumbar vertebra was used to detect sarcopenia in the early stages. Clinical malnutrition was defined according to global clinical nutrition criteria. Clinical outcomes included the rate of surgery and infections within one year. (3) Results: A total of 63 CD patients (34 M; aged 44 ± 17 years) were recruited, and 48 patients (68.3%) were sarcopenic. Malnutrition occurred in 28 patients (44.4%) with a significant correlation between body mass index (BMI) and sarcopenia (r = 0.5, p < 0.001). The overall rate of surgery was 33%, without a significant difference between sarcopenic and non-sarcopenic (p = 0.41). The rate of infection in patients with sarcopenia was significantly higher than in non-sarcopenic (42%vs15%, p = 0.03). BMI (OR 0.73,95%, CI 0.57–0.93) and extraintestinal manifestations (EIM) (OR 19.2 95%, CI 1.05–349.1) were predictive of sarcopenia (p < 0.05). (4) Conclusions: Sarcopenia was associated with an increased rate of infections, and it was observed in 68.3% of the Caucasian cohort with active CD.Keywords
This publication has 57 references indexed in Scilit:
- Epidemiology and risk factors for IBDNature Reviews Gastroenterology & Hepatology, 2015
- Infection risk associated with anti-TNF-α agents: a reviewExpert Opinion on Drug Safety, 2015
- Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2015
- Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantationLiver Transplantation, 2013
- Ratio of Visceral to Subcutaneous Fat Area Is a Biomarker of Complicated Crohn's DiseaseClinical Gastroenterology and Hepatology, 2011
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Sarcopenia is prevalent in patients with Crohnʼs disease in clinical remissionInflammatory Bowel Diseases, 2008
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based studyThe Lancet Oncology, 2008
- Noninvasive Diagnosis of Small Bowel Crohnʼs Disease: Combined Use of Bowel Sonography and Tc-99M-Hmpao Leukocyte ScintigraphyInflammatory Bowel Diseases, 2005
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980